Pulmonary circulation and disease

Citations 11-20 of 26 total displayed.

Past content (since May 1999):

Editorial Commentaries
Nanoparticle-Mediated Drug Delivery and Pulmonary Hypertension

James C. Bonner, Jeffrey W. Card, and Darryl C. Zeldin
Hypertension 2009;53:751-753; published online before print as doi:10.1161/HYPERTENSIONAHA.108.122846 [Full text]  

Original Articles
Nanoparticle-Mediated Delivery of Nuclear Factor B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

Satoshi Kimura, Kensuke Egashira, Ling Chen, Kaku Nakano, Eiko Iwata, Miho Miyagawa, Hiroyuki Tsujimoto, Kaori Hara, Ryuichi Morishita, Katsuo Sueishi, Ryuji Tominaga, and Kenji Sunagawa
Hypertension 2009;53:877-883; published online before print as doi:10.1161/HYPERTENSIONAHA.108.121418 [Abstract] [Full text]  

Editorial Commentary
Nanoparticle-Mediated Drug Delivery and Pulmonary Hypertension

James C. Bonner, Jeffrey W. Card, and Darryl C. Zeldin
Hypertension published March 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.122846 [Abstract]  

Scientific Contributions
Nanoparticle-Mediated Delivery of Nuclear Factor B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

Satoshi Kimura, Kensuke Egashira, Ling Chen, Kaku Nakano, Eiko Iwata, Miho Miyagawa, Hiroyuki Tsujimoto, Kaori Hara, Ryuichi Morishita, Katsuo Sueishi, Ryuji Tominaga, and Kenji Sunagawa
Hypertension published March 23, 2009, doi:10.1161/HYPERTENSIONAHA.108.121418 [Abstract]  

Original Articles
Low Concentrations of Sphingosylphosphorylcholine Enhance Pulmonary Artery Vasoreactivity: The Role of Protein Kinase C and Ca²⁺ Entry

Vladimir A. Snetkov, Gavin D. Thomas, Bonnie Teague, Richard M. Leach, Yasin Shaifta, Greg A. Knock, Philip I. Aaronson, and Jeremy P.T. Ward
Hypertension 2008;51:239-245; published online before print as doi:10.1161/HYPERTENSIONAHA.107.104802 [Abstract] [Full text]  

Scientific Contributions
Low Concentrations of Sphingosylphosphorylcholine Enhance Pulmonary Artery Vasoreactivity. The Role of Protein Kinase C and Ca²⁺ Entry

Vladimir A. Snetkov, Gavin D. Thomas, Bonnie Teague, Richard M. Leach, Yasin Shaifta, Greg A. Knock, Philip I. Aaronson, and Jeremy P.T. Ward
Hypertension published December 24, 2007, doi:10.1161/HYPERTENSIONAHA.107.104802 [Abstract]  

Original Articles
Adenoassociated Virus–Mediated Prostacyclin Synthase Expression Prevents Pulmonary Arterial Hypertension in Rats

Takayuki Ito, Takashi Okada, Jun Mimuro, Hiroshi Miyashita, Ryosuke Uchibori, Masashi Urabe, Hiroaki Mizukami, Akihiro Kume, Masafumi Takahashi, Uichi Ikeda, Yoichi Sakata, Kazuyuki Shimada, and Keiya Ozawa
Hypertension 2007;50:531-536; published online before print as doi:10.1161/HYPERTENSIONAHA.107.091348 [Abstract] [Full text]  

Scientific Contributions
Adenoassociated Virus-Mediated Prostacyclin Synthase Expression Prevents Pulmonary Arterial Hypertension in Rats

Takayuki Ito, Takashi Okada, Jun Mimuro, Hiroshi Miyashita, Ryosuke Uchibori, Masashi Urabe, Hiroaki Mizukami, Akihiro Kume, Masafumi Takahashi, Uichi Ikeda, Yoichi Sakata, Kazuyuki Shimada, and Keiya Ozawa
Hypertension published July 16, 2007, doi:10.1161/HYPERTENSIONAHA.107.091348 [Abstract]  

Original Articles
Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension

Ian Morecroft, Yvonne Dempsie, Michael Bader, Diego J. Walther, Katarina Kotnik, Lynn Loughlin, Margaret Nilsen, and Margaret R. MacLean
Hypertension 2007;49:232-236; published online before print as doi:10.1161/01.HYP.0000252210.58849.78 [Abstract] [Full text]  

Scientific Contributions
Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension

Ian Morecroft, Yvonne Dempsie, Michael Bader, Diego J. Walther, Katarina Kotnik, Lynn Loughlin, Margaret Nilsen, and Margaret R. MacLean
Hypertension published November 27, 2006, doi:10.1161/01.HYP.0000252210.58849.78 [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3